<DOC>
	<DOCNO>NCT01600365</DOCNO>
	<brief_summary>The purpose study study use ganciclovir gel 0.3 % treatment conjunctivitis cause adenovirus .</brief_summary>
	<brief_title>Evaluate Use Ganciclovir Gel 0.3 % Treatment Conjunctivitis Caused Adenovirus</brief_title>
	<detailed_description>To evaluate efficacy tolerability ganciclovir ophthalmic gel treatment conjunctivitis compare placebo ( ophthalmic gel ) . Visual acuity test slit lamp examination ( biomicroscopy ) perform visit ass signs/symptoms regression disease .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Adenoviridae Infections</mesh_term>
	<mesh_term>Conjunctivitis , Inclusion</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Patients eye disease clinical diagnosis adenovirus conjunctivitis . Patients gender age 18 year . Patients pregnant nursing . Patients able ( legally mentally ) understand sign inform consent sign . Patients presence corticosteroid , either topical ocular , periocular , intraocular systemic , less 30 day enrollment make drug suspension . Patients serious systemic disease like AIDS , cancer , etc. , opinion investigator , may put patient risk . Patient single eye vision one eye .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Conjunctivitis</keyword>
	<keyword>adenovirus .</keyword>
</DOC>